BMJ:早期手术重建对急性前十字韧带断裂患者预后的影响

2021-03-12 MedSci原创 MedSci原创

对于急性前十字韧带断裂患者,接受早期手术重建后,在症状、膝关节功能和参与体育运动的能力方面有所改善

前十字韧带(ACL)断裂是一种常见损伤,会导致膝盖疼痛、肿胀、继发性不稳定症状、半月板和软骨损伤,前十字韧带断裂患者的骨关节炎风险增加了10倍,每10万人年发病49-75例。KANON研究显示,非手术治疗联合运动可治疗50%的ACL断裂患者。
近日研究人员比较了前十字韧带断裂后早期手术重建vs 3个月非手术治疗后选择性延迟重建对患者预后的影响。
COMPARE研究在荷兰6家医院开展,2011-16年间,年龄在18-65岁的急性ACL断裂患者参与,其中85名患者接受早期手术ACL重建,82人在三个月非手术治疗后,再选择是否进行ACL重建。研究的主要终点为症状、膝关节功能和参与体育活动的能力,在24个月的每个时间点通过IKDC评分评估。
 
患者平均年龄31.3岁,67名(40%)女性,163名(98%)患者完成了试验。延迟ACL重建组中,41例(50%)患者在随访期间进行了重建。24个月后,早期ACL重建组IKDC评分优于延迟重建组,但差异不显著(84.7 vs 79.4,组间差异5.3)。研究开始后前三个月,延迟ACL重建组IKDC得分优于早期手术重建组(组间差异为-9.3),但9个月的随访显示,早期ACL重建组表现较好,在12个月后,两组之间的差异较小。随访过程中,早期ACL重建组发生了3例对侧ACL断裂和4例对侧ACL再断裂,延迟ACL重建组中发生了2例对侧ACL再断裂和1例对侧ACL断裂。
研究认为,对于急性前十字韧带断裂患者,接受早期手术重建后,在症状、膝关节功能和参与体育运动的能力方面有所改善
 
原始出处:
 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849203, encodeId=08801849203ed, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sun May 02 16:50:53 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1692192, encodeId=049a169219203, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Tue Feb 22 19:50:53 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507450, encodeId=a0ba150e4503a, content=<a href='/topic/show?id=16b7100010c7' target=_blank style='color:#2F92EE;'>#韧带#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100010, encryptionId=16b7100010c7, topicName=韧带)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9b19890064, createdName=juliusluan81, createdTime=Sun Mar 14 09:50:53 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-05-02 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849203, encodeId=08801849203ed, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sun May 02 16:50:53 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1692192, encodeId=049a169219203, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Tue Feb 22 19:50:53 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507450, encodeId=a0ba150e4503a, content=<a href='/topic/show?id=16b7100010c7' target=_blank style='color:#2F92EE;'>#韧带#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100010, encryptionId=16b7100010c7, topicName=韧带)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9b19890064, createdName=juliusluan81, createdTime=Sun Mar 14 09:50:53 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1849203, encodeId=08801849203ed, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sun May 02 16:50:53 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1692192, encodeId=049a169219203, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Tue Feb 22 19:50:53 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507450, encodeId=a0ba150e4503a, content=<a href='/topic/show?id=16b7100010c7' target=_blank style='color:#2F92EE;'>#韧带#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100010, encryptionId=16b7100010c7, topicName=韧带)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9b19890064, createdName=juliusluan81, createdTime=Sun Mar 14 09:50:53 CST 2021, time=2021-03-14, status=1, ipAttribution=)]